RT @MarioBenjaminG3: Hiperkalemia en el tratamiento con inhibidores del RAS durante falla aguda no se asocia a mayor mortalidad. https://t.…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @MarioBenjaminG3: Hiperkalemia en el tratamiento con inhibidores del RAS durante falla aguda no se asocia a mayor mortalidad. https://t.…
RT @DrRajivsankar: Incident hyperkalemia common in pts hospitalized for acute #heartfailure & not ass. with bad outcomes. Incident hyperkal…
Incident hyperkalemia common in pts hospitalized for acute #heartfailure & not ass. with bad outcomes. Incident hyperkalemia leads to down-titration of MRAs, but pts who maintained/increased dose of MRAs/ACE during acute HF hosp had better 180d surviva
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
RT @BSHeartFailure: Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With…
Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality - ScienceDirect https://t.co/gpBMl6ZcCf
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
Hiperkalemia en el tratamiento con inhibidores del RAS durante falla aguda no se asocia a mayor mortalidad.
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
RT @paomorejon: 📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se as…
📌Hiperkalemia e #insuficienciacardiaca aguda ⤴️K 35% •17% >/= 5.5 mEq/l •5% > 6.0 mEq/l ⤵️K 17% 👍🏻Si es accidental no se asocia con malos resultados ⤵️dosis de MRA⚠️⚠️HR:1.73☠️ ✅Mejor si se mantienen o ⤴️las dosis de IECAs/ARAII o MRA https://t.co/S
Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. https://t.co/1x7ePOiIAB
RT @mendez_bailon: Interesting article "Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and The…
RT @mendez_bailon: Interesting article "Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and The…
Interesting article "Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality" (via #pubmedontap) #SEMItuit @IcyfaSemi https://t.co/ziRF7BZAel
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @Office_j: 【高K血症を呈したADHF例、RAAS阻害薬はどうする?/ JACC】 ADHF入院例対象RCT参加1589例解析:入院中35%が高K血症を発症。発症例中、アルド拮抗薬、RAS-iを減量しなかった例では、減量 [必要] 例に比べ、180日死亡リスク…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @Office_j: 【高K血症を呈したADHF例、RAAS阻害薬はどうする?/ JACC】 ADHF入院例対象RCT参加1589例解析:入院中35%が高K血症を発症。発症例中、アルド拮抗薬、RAS-iを減量しなかった例では、減量 [必要] 例に比べ、180日死亡リスク…
RT @Office_j: 【高K血症を呈したADHF例、RAAS阻害薬はどうする?/ JACC】 ADHF入院例対象RCT参加1589例解析:入院中35%が高K血症を発症。発症例中、アルド拮抗薬、RAS-iを減量しなかった例では、減量 [必要] 例に比べ、180日死亡リスク…
RT @Office_j: 【高K血症を呈したADHF例、RAAS阻害薬はどうする?/ JACC】 ADHF入院例対象RCT参加1589例解析:入院中35%が高K血症を発症。発症例中、アルド拮抗薬、RAS-iを減量しなかった例では、減量 [必要] 例に比べ、180日死亡リスク…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
@InternaUninorte
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
【高K血症を呈したADHF例、RAAS阻害薬はどうする?/ JACC】 ADHF入院例対象RCT参加1589例解析:入院中35%が高K血症を発症。発症例中、アルド拮抗薬、RAS-iを減量しなかった例では、減量 [必要] 例に比べ、180日死亡リスクは有意に低。 https://t.co/OzMZCKZ2Pk
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
RT @JTLLERGO: Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated…
Hyperkalemia: 📍 is common in patients hospitalized for acute HF and is not associated with adverse outcomes. 📍Is associated with down-titration of MRAs, but patients who maintained or increased dose of MRAs and/or ACEi/ARB had better 180-day survival. htt